Top Markets
Coin of the day
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
Classement en actions #24577
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
Prix de l'action
$1.48
Dernière synchronisation: 2025-03-24
Capitalisation boursière
$59.05M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
GB
Échange Achilles Therapeutics plc (ACHL)

Catégorie

Historique du prix de l'action pour Achilles Therapeutics plc (ACHL)
Prix de clôture le plus élevé : $1.42 le 2025-03-01

Prix de clôture le plus bas : $16.55 le 2021-03-01
Historique du prix de l'action de Achilles Therapeutics plc de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2025 35.96%
2024 21.05%
2023 -23.13%
2022 -77.06%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$547.38 37.72%
US
$1.05K 58.85%
NL
$118.70 -18.24%
AU
$140.47 435.74%
US
$770.19 9.84%
CH